Li-Zhen He

3.7k total citations
41 papers, 2.2k citations indexed

About

Li-Zhen He is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Li-Zhen He has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 18 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Li-Zhen He's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (12 papers) and CAR-T cell therapy research (11 papers). Li-Zhen He is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (12 papers) and CAR-T cell therapy research (11 papers). Li-Zhen He collaborates with scholars based in United States, China and United Kingdom. Li-Zhen He's co-authors include Pier Paolo Pandolfi, Raymond P. Warrell, Tibor Keler, Carla Tribioli, Daniela Peruzzi, Arthur Zelent, Martin Ruthardt, Fabien Guidez, Sue Zhong and Peter C. Grayson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Investigation.

In The Last Decade

Li-Zhen He

40 papers receiving 2.2k citations

Peers

Countries citing papers authored by Li-Zhen He

Since Specialization

Citations

This map shows the geographic impact of Li-Zhen He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Zhen He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Zhen He more than expected).

Fields of papers citing papers by Li-Zhen He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li-Zhen He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Zhen He. The network helps show where Li-Zhen He may publish in the future.

Co-authorship network of co-authors of Li-Zhen He

This figure shows the co-authorship network connecting the top 25 collaborators of Li-Zhen He. A scholar is included among the top collaborators of Li-Zhen He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li-Zhen He. Li-Zhen He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selenium nanoparticles restrain recurrence of cervical cancer in drug-free period by inhibiting the expression of ABC transporters 2025 ·Nano Today ·Ting Liu, Shuya Pan, Qingfeng Zhou, Ziyi Yang, Zihan Zhang, (unknown), Li-Zhen He, (unknown), (unknown), Tianfeng Chen, Xueqiong Zhu	1
2	Translational Selenium Nanoparticles Promotes Clinical Non‐small‐cell Lung Cancer Chemotherapy via Activating Selenoprotein‐driven Immune Manipulation 2025 ·Advanced Materials ·(unknown), (unknown), Jinlin Wang, (unknown), (unknown), Zushuang Xiong, Guanning Huang, Jianwei Yang, (unknown), Rui Qiao, Zhongwen Yuan, Li-Zhen He, Tianfeng Chen	9
3	Tissue-specific modifier alleles determine Mertk loss-of-function traits 2022 ·eLife ·Yemsratch T. Akalu, (unknown), Marleen Ansems, Lindsey D. Hughes, (unknown), (unknown), (unknown), Li-Zhen He, Diego Alvarado, Tibor Keler, Yong Kong, William M. Philbrick, Marcus Bosenberg, Silvia C. Finnemann, Antonio Iavarone, Anna Lasorella, Carla V. Rothlin, Sourav Ghosh	27
4	Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice 2021 ·Cancer Immunology Immunotherapy ·Anna Wasiuk, (unknown), (unknown), Jenifer Widger, Andrea Crocker, Laura Vitale, Henry C. Marsh, Tibor Keler, Li-Zhen He	4
5	CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells 2020 ·Communications Biology ·Rebeca Arroyo Hornero, Christos Georgiadis, Hua Peng, Dominik Trzupek, Li-Zhen He, Waseem Qasim, John A. Todd, Ricardo C. Ferreira, Kathryn J. Wood, Fadi Issa, Joanna Hester	39
6	Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes 2019 ·ImmunoHorizons ·(unknown), Riyasat Ali, (unknown), Ignacio Guerrero‐Ros, (unknown), Li-Zhen He, Tibor Keler, Teresa P. DiLorenzo	2
7	CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response 2018 ·OncoImmunology ·Katherine A. Riccione, Li-Zhen He, Peter E. Fecci, Pamela K. Norberg, Carter M. Suryadevara, Adam M. Swartz, Patrick Healy, Elizabeth A. Reap, Tibor Keler, Qi-Jing Li, Kendra L. Congdon, Luis Sánchez-Pérez, John H. Sampson	10
8	Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy 2018 ·Cancer Immunology Immunotherapy ·Laura Vitale, Lawrence J. Thomas, Li-Zhen He, Thomas J. O’Neill, Jenifer Widger, Andrea Crocker, Karuna Sundarapandiyan, James R. Storey, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Goldstein, Henry C. Marsh, Tibor Keler	39
9	CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy 2017 ·The Journal of Immunology ·Anna Wasiuk, James Testa, (unknown), (unknown), Laura Vitale, Jenifer Widger, Andrea Crocker, Lawrence J. Thomas, J. Goldstein, Henry C. Marsh, Tibor Keler, Li-Zhen He	40
10	M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1 2017 ·Cell Reports ·Murugesan V. S. Rajaram, Eusondia Arnett, Abul Azad, Evelyn Guirado, Bin Ni, (unknown), Li-Zhen He, Tibor Keler, Lawrence J. Thomas, William P. Lafuse, Larry S. Schlesinger	100
11	Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity 2014 ·OncoImmunology ·Lawrence J. Thomas, Li-Zhen He, Henry C. Marsh, Tibor Keler	23
12	Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine 2014 ·Cellular and Molecular Immunology ·Li-Zhen He, (unknown), (unknown), Henry C. Marsh, Tibor Keler	22
13	Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models 2013 ·Journal for ImmunoTherapy of Cancer ·Li-Zhen He, Lawrence J. Thomas, James Testa, (unknown), (unknown), Russell A. Hammond, Laura Vitale, Henry C. Marsh, Tibor Keler	3
14	Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice 2012 ·Breast Cancer Research ·Bei Wang, Neeha Zaidi, Li-Zhen He, Li Zhang, Janelle Kuroiwa, Tibor Keler, Ralph M. Steinman	74
15	Targeting antigens to the human mannose receptor expressed in transgenic mice elicits potent CD4 and CD8 responses in vivo 2006 ·Cancer Research ·Li-Zhen He, Andrea Crocker, Laura Vitale, Thomas J. O’Neill, Raphael Clynes, Tibor Keler	1
16	Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules 2004 ·The Journal of Immunology ·Venky Ramakrishna, Jack Treml, Laura Vitale, John E. Connolly, Thomas J. O’Neill, Patricia Smith, Charles Jones, Li-Zhen He, J. Goldstein, Paul K. Wallace, Tibor Keler, M. Endres	97
17	Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia 2001 ·Journal of Clinical Investigation ·Li-Zhen He, (unknown), Peter C. Grayson, Sue Zhong, Raymond P. Warrell, Richard A. Rifkind, Paul A. Marks, Victoria M. Richon, Pier Paolo Pandolfi	221
18	In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications 1999 ·Oncogene ·Li-Zhen He, Taha Merghoub, Pier Paolo Pandolfi	92
19	Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL 1998 ·Nature Genetics ·Li-Zhen He, Fabien Guidez, Carla Tribioli, Daniela Peruzzi, Martin Ruthardt, Arthur Zelent, Pier Paolo Pandolfi	473
20	Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes 1995 ·Leukemia Research ·(unknown), Li-Zhen He, Ghulam J. Mufti	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact